A comprehensive review on complex generics

Authors

  • Pratibha A. Avhad
  • Shailesh S. Chalikwar
  • Bhushan A. Bhairav

DOI:

https://doi.org/10.31489/2022bmg1/129-135

Keywords:

complex generics, GDUFA, governing guidelines, challenges, opportunities

Abstract

Complex generic is a generic with multifaceted dynamic constituent, multifaceted preparation, multifaceted path of administration, or multifaceted medicine device mixture. For over three decades, generics have been a desirable and cost-effective production route. Since the pharmaceutical cluster aimed at cheap generic medicines takes active development, biopharmaceutical firms remain focusingon multifaceted medicine, which provides extra worth towards affected person via speaking extra unmet requirements besides allow them to attain pharmaceutical souk variation and advanced using. The complexity of chemisimilar and biosimilar products has limited the replacement of unwieldy large-scale clinical trial data withsimpler, single-dose, pharmacokinetic and pharmacodynamic comparisons between test and reference. This limitation should be recognized by defining the sensitivity of any test used to detect differences in dose.

Downloads

Published

2022-03-30

Issue

Section

Articles